default author photo

Bent Winding

Ascendis Pharma A/S

SCHOLARLY PAPERS

1

DOWNLOADS

132

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Once-Weekly TransCon CNP in Children with Achondroplasia (ACcomplisH): A Phase 2, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Trial

Number of pages: 29 Posted: 27 Jun 2023
University of Melbourne - Murdoch Children's Research Institute, University of Missouri Children’s Hospital, Copenhagen University College - Hospital Rigshospitalet, University of Arkansas for Medical Sciences, Baylor College of Medicine, Nemours Children's Hospital, University of Wisconsin-Madison - School of Medicine and Public Health, Johannes Kepler University Linz, State University of New York (SUNY) - University at Buffalo, Children’s Minnesota, University of Auckland - The Liggins Institute, Children's Hospital Colorado, Children's Hospital Colorado, Charité - Universitätsmedizin Berlin - Center for Chronically Sick Children, Hospital Pediátrico de Coimbra, Ascendis Pharma Inc., Ascendis Pharma Inc., Ascendis Pharma Inc., Ascendis Pharma Inc., Ascendis Pharma A/S, Ascendis Pharma A/S, Ascendis Pharma Inc. and Children’s Health Ireland
Downloads 132 (551,165)

Abstract:

Loading...

Achondroplasia, C-type Natriuretic Peptide, growth, TransCon CNP, Paediatric